Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Rho Supports Follow-up Study Demonstrating Benefit of Early Peanut Consumption is Maintained Following One Year of Peanut Avoidance

    Mar 4, 2016, 15:19 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Mar 4, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, is part of a newly published clinical trial that found that children who consumed peanut-containing foods regularly from infancy to age five and then avoided peanut for one year did not become allergic to peanut
    Full story
  • PrecisionFDA Consistency Challenge Will Benchmark the Basic Software Tools of Genetic Research

    Mar 4, 2016, 10:30 AM by Michael Croft
    Bio-IT World | The first challenge hosted in the FDA's cloud-based precisionFDA platform will score different computational pipelines' ability to accurately call variants from raw DNA sequence data, in a public competition meant to shed light on some of the most essential tools in genomics.
    Full story
  • Rare disease or rare success: a tale of two genomes

    Mar 4, 2016, 05:39 AM by Michael Croft
    CAMBRIDGE, UK - Mar 4, 2016 - When Congenica heard how an Iowa woman with a severe muscle wasting disease had not only diagnosed the genetic basis of her condition, but also realised it was linked it to a muscle-bound phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep, the company was inspired and wanted to see if they could help
    Full story
  • Husson University to Launch MBA with a Concentration in Biotechnology and Innovation in Fall 2016

    Mar 3, 2016, 20:02 PM by Michael Croft
    BANGOR, ME, UNITED STATES - Mar 4, 2016 - Husson University announced today that it is launching six new programs in science, technology and management designed to prepare students for career success in current and emerging fields
    Full story
  • Omicia Announces Appointment of Matt Tindall as Chief Executive Officer

    Mar 3, 2016, 14:40 PM by Michael Croft
    OAKLAND, CA - Mar 3, 2016 - Omicia, the leading provider of clinical genome interpretation software and services, announced that Matt Tindall has been appointed CEO and a member of the company’s Board of Directors, effective March 1st, 2016
    Full story
  • Alaska’s Biotech Sugar Daddy Is Showering Money on Startups

    Mar 3, 2016, 11:20 AM by Michael Croft
    Bloomberg.com | Alaska's economic eminence stems from the discovery of oil on the North Slope in the 1960s. But its more recent crown as a biotech sugar daddy started in March 2013 with a chance meeting on a flight from Boston to Seattle.
    Full story
  • OCF delivers new 181 Teraflop HPC resource for University College London

    Mar 2, 2016, 12:05 PM by Michael Croft
    LONDON, UNITED KINGDOM - Mar 2, 2016 -
    • UCL's new 'GRACE' machine to benefit researchers from across the University
    • Large scale parallel computing returns to the University
    • Designed and integrated by OCF
    • Linpack benchmark conducted by OCF delivered 181x
    Full story
  • Precision for Medicine Transforms Big Data Into Actionable Information

    Mar 2, 2016, 11:35 AM by Michael Croft
    Bio-IT World | Precision for Medicine will formally launch its immuno-analytics platform solution this month, the latest addition to its PATH suite of tools for contending with big 'omics data even when working with small sample sizes.
    Full story
  • BC Platforms and Microsoft to Provide Expanded Genomic Data Management Solutions in the Cloud

    Mar 2, 2016, 03:46 AM by Michael Croft
    BASEL, SWITZERLAND - Mar 2, 2016 - BC Platforms, a world leader in genomic data management solutions, today announced that it will collaborate with Microsoft to use the Microsoft Azure cloud platform and services to provide integrated genomic data management solutions in healthcare
    Full story
  • MAVERIX BIOMICS Offers Free Trial of Self-Service RNA-Seq Data Analysis for Next Generation Sequencing (NGS) Datasets

    Mar 1, 2016, 10:35 AM by Michael Croft
    SAN MATEO - Mar 1, 2016 - Maverix Biomics, a leading Next Generation Sequencing (NGS) data analysis software company, today made available a free 30-day trial of the Maverix WAVES™ RNA-Seq Gene Expression Analysis solution
    Full story
  • February News and Product Briefs

    Mar 1, 2016, 10:30 AM by Michael Croft
    Bio-IT World | The latest products and announcements from around the industry, including the introduction of Arvados to Microsoft Azure, and an online solution for metagenomics through One Codex.
    Full story
  • Adaptive Computing Launches High Productivity Remote Visualization

    Feb 29, 2016, 15:11 PM by Michael Croft
    PROVO, UT, US - Feb 29, 2016 - Adaptive Computing, provider of award-winning workload and resource orchestration software, announces it has integrated Remote Visualization with Moab’s workload submission portal, Viewpoint, in order to improve ease-of-use and increase user productivity
    Full story
  • New CRISPR-Like Defense System Discovered in Giant Viruses

    Feb 29, 2016, 13:05 PM by Michael Croft
    The Atlantic | The bizarre Mimivirus has become even more perplexing, as scientists uncover a genetic element called MIMIVRE, highly analogous to CRISPR, that it uses to fight off smaller viruses.
    Full story
  • NanoString Reveals Novel Sequencing Method for Cancer Assays

    Feb 29, 2016, 12:05 PM by Michael Croft
    Bio-IT World | NanoString Technologies, a Seattle company with a small but comfortable niche in automated genetic analysis, is preparing to make the leap into DNA and RNA sequencing, with a highly novel process it calls Hyb and Seq.
    Full story
  • Rare Disease Day focuses on new approach to finding treatment

    Feb 29, 2016, 05:19 AM by Michael Croft
    CAMBRIDGE, UK - Feb 29, 2016 - 2,200 babies will be born in the UK on 29th February, of which 30 will die of a rare disease before they are five years old*
    Full story
  • Obama Is Using the Bully Pulpit to Set Patient Data Free

    Feb 25, 2016, 14:05 PM by Michael Croft
    Forbes | At a White House meeting on the President's Precision Medicine Initiative, open data, shared with patients and between centers, is the centerpiece of a national plan.
    Full story
  • Verily, Vanderbilt Named to Launch U.S. Precision Medicine Pilot

    Feb 25, 2016, 10:21 AM by Michael Croft
    Reuters | The National Institutes of Health on Thursday named Verily, formerly Google Life Sciences, as advisor to Nashville's Vanderbilt University in a pilot program to launch the Precision Medicine Initiative outlined by President Barack Obama last year.
    Full story
  • Certara Introduces Phoenix Technology Services to Optimize Pharma R&D Productivity

    Feb 25, 2016, 08:17 AM by Michael Croft
    PRINCETON, NJ - Feb 25, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced the introduction of Phoenix® Technology Services
    Full story
  • Illumina Sues Oxford Nanopore Technologies Over Composition of Nanopores

    Feb 24, 2016, 14:15 PM by Michael Croft
    Bio-IT World | Oxford Nanopore Technologies, creator of the world's first and only nanopore sequencer, has found itself the target of a lawsuit by genomics giant Illumina, which does not make a nanopore sequencer but does license two patents related to a very specific iteration of the technology.
    Full story
  • OPKO's GeneDx Participating in the Molecular Medicine Tri-Conference 2016 in San Francisco

    Feb 24, 2016, 09:29 AM by Michael Croft
    MIAMI, FL - Feb 24, 2016 - OPKO Health, Inc. (NYSE: OPK) announced today that GeneDx was invited to participate in the Molecular Medicine Tri-Conference 2016, being held at the Moscone North Convention Center in San Francisco, California from March 6th - 11th, 2016, and will also be exhibiting at Booth 606
    Full story
  • «
  • 341
  • 342
  • 343
  • 344
  • 345
  • 346
  • 347
  • 348
  • 349 (current)
  • 350
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy